SpringWorks Therapeutics price target lowered to $78 from $80 at Guggenheim
Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
Long Island Press7h
Guggenheim Elementary guest speaker shares experiences in Africa
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Salesforce Stock’s AI Rally Is Over, Analyst Says. Why Now Could Be the Time to Sell.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.
Guggenheim Doubts Salesforce's Agentic AI Agentforce as an Effective Growth Factor
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
Time Out16d
All the art exhibits coming to NYC's Guggenheim Museum in 2025
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
Palo Alto Networks downgraded to Sell from Neutral at Guggenheim
Guggenheim downgraded Palo Alto Networks (PANW) to Sell from Neutral with a $130 price target Stay Ahead of the Market:Discover outperforming ...
MongoDB Gains On Buy Call. Why Analyst Is Bullish Software Stock Can Shake Off Slump.
MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.
Orphism, the early 20th century art movement, in focus at New York’s Guggenheim Museum
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
Morningstar20h
Guggenheim Macro Opportunities A
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...
Hosted on MSN2d
Guggenheim Upgrades MongoDB (MDB)
Fintel reports that on January 6, 2025, Guggenheim upgraded their outlook for MongoDB (NasdaqGM:MDB) from Neutral to Buy.